H. Jeffrey Wilkins
2020
In 2020, H. Jeffrey Wilkins earned a total compensation of $1.5M as Former Chief Medical Officer at Avalo Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $178,000 |
|---|---|
| Option Awards | $974,244 |
| Salary | $335,534 |
| Total | $1,487,778 |
Wilkins received $974.2K in option awards, accounting for 65% of the total pay in 2020.
Wilkins also received $178K in non-equity incentive plan and $335.5K in salary.
Rankings
In 2020, H. Jeffrey Wilkins' compensation ranked 6,850th out of 13,090 executives tracked by ExecPay. In other words, Wilkins earned more than 47.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,850 out of 13,090 | 48th |
Division Manufacturing | 2,854 out of 5,624 | 49th |
Major group Chemicals And Allied Products | 1,152 out of 2,257 | 49th |
Industry group Drugs | 992 out of 1,957 | 49th |
Industry Pharmaceutical Preparations | 738 out of 1,462 | 50th |
Source: SEC filing on April 25, 2022.
Wilkins' colleagues
We found one more compensation record of an executive who worked with H. Jeffrey Wilkins at Avalo Therapeutics in 2020.
2020
Michael Cola
Avalo Therapeutics